Antigenic and molecular characterization of low pathogenic avian influenza A(H9N2) viruses in sub-Saharan Africa from 2017 through 2019

Emerg Microbes Infect. 2021 Dec;10(1):753-761. doi: 10.1080/22221751.2021.1908097.

Abstract

Sub-Saharan Africa was historically considered an animal influenza cold spot, with only sporadic highly pathogenic H5 outbreaks detected over the last 20 years. However, in 2017, low pathogenic avian influenza A(H9N2) viruses were detected in poultry in Sub-Saharan Africa. Molecular, phylogenetic, and antigenic characterization of isolates from Benin, Togo, and Uganda showed that they belonged to the G1 lineage. Isolates from Benin and Togo clustered with viruses previously described in Western Africa, whereas viruses from Uganda were genetically distant and clustered with viruses from the Middle East. Viruses from Benin exhibited decreased cross-reactivity with those from Togo and Uganda, suggesting antigenic drift associated with reduced replication in Calu-3 cells. The viruses exhibited mammalian adaptation markers similar to those of the human strain A/Senegal/0243/2019 (H9N2). Therefore, viral genetic and antigenic surveillance in Africa is of paramount importance to detect further evolution or emergence of new zoonotic strains.

Keywords: Africa; Influenza virus; antigenic cartography; one health; phylogeny.

MeSH terms

  • Africa South of the Sahara
  • Animals
  • Antibodies, Viral / immunology
  • Antigenic Variation
  • Chickens / virology
  • Cross Reactions
  • Evolution, Molecular
  • Humans
  • Influenza A Virus, H9N2 Subtype / genetics*
  • Influenza A Virus, H9N2 Subtype / immunology*
  • Influenza A Virus, H9N2 Subtype / pathogenicity
  • Influenza A Virus, H9N2 Subtype / physiology
  • Influenza in Birds / virology*
  • Influenza, Human / virology
  • Phylogeny
  • Poultry Diseases / virology*
  • Virulence
  • Virus Replication

Substances

  • Antibodies, Viral

Grants and funding

This work was supported by Department of Defense: [grant number P0136_19_KY_08]; National Institute of Allergy and Infectious Diseases: [grant number CEIRS HHSN266200700005C, CEIRS HHSN272201400006C].